Interaction of α-synuclein and synphilin-1: Effect of Parkinson's disease-associated mutations

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 929-934

  Kawamata, Hibiki ^a   McLean, Pamela J ^a   Sharma, Nutan ^a   Hyman, Bradley T ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

synuclein; FRET; Human neuroglioma cells; Parkinson's disease; Synphilin 1

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN; SYNPHILIN 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFOCAL MICROSCOPY; ENERGY TRANSFER; FLUORESCENCE; GENE MUTATION; GLIOMA CELL; HUMAN; HUMAN CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

ALPHA-SYNUCLEIN; BLOTTING, WESTERN; CARRIER PROTEINS; ENERGY TRANSFER; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MUTAGENESIS, SITE-DIRECTED; MUTATION; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBCELLULAR FRACTIONS; SYNUCLEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034996655     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00301.x     Document Type: Article

References (14)

1. Baba M., Nakajo S., Tu P. H., Tomita T., Nakaya K., Lee V. M., Trojanowski J. Q. and Iwatsubo T. (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884.
2. Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E. and Lansbury P. T. Jr (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571-576.
3. Engelender S., Kaminsky Z., Guo X., Sharp A. H., Amaravi R. K., Kleiderlein J. J., Margolis R. L., Troncoso J. C., Lanahan A. A., Worley P. F., Dawson V. L., Dawson T. M. and Ross C. A. (1999) Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22, 110-114.
4. George J. M., Jin H., Woods W. S. and Clayton D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361-372.
5. Giasson B. I., Uryu K., Trojanowski J. Q. and Lee V. M. (1999) Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274, 7619-7622.
6. Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G. and Goedert M. (1998) Binding of α-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273, 26292-26294.
7. Knowles R. B., Chin J., Ruff C. T. and Hyman B. T. (1999) Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 58, 1090-1098.
8. Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. and Riess O. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
9. McLean P. J., Kawamata H., Ribich S. and Hyman B. T. (2000) Membrane association and protein conformation of α-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275, 8812-8816.
10. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J. M., Farer M. and Wolozin B. (2000) The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20, 6048-6054.
11. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I. and Nussbaum R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
12. Spillantini M. G., Crowther R. A., Jakes R., Hasegawa M. and Goedert M. (1998) α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469-6473.
13. Wakabayashi K., Engelender S., Yoshimoto M., Tsuji S., Ross C. A. and Takahashi H. (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 47, 521-523.
14. Wu P, and Brand L. (1994) Resonance energy transfer: Methods and applications. Anal. Biochem. 218, 1-13.